Back to Search
Start Over
Trial Watch.
- Source :
- Nature Reviews Cancer; Apr2013, Vol. 13 Issue 4, p223-223, 1p
- Publication Year :
- 2013
-
Abstract
- The article discusses clinical trials on oncolytics and prevention of disease relapse. It references the studies "Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer," and "Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients." It mentions the randomized Phase II dose-finding trial of JX-594 For hepatocellular carcinoma treatment and the efficacy of CD8+cytotoxic T lymphocytes (CTLs).
Details
- Language :
- English
- ISSN :
- 1474175X
- Volume :
- 13
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- Nature Reviews Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 86214442
- Full Text :
- https://doi.org/10.1038/nrc3501